+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Teva Pharmaceutical Industries Ltd. - logo

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

From
T-cell Lymphoma Market 2024-2028 - Product Thumbnail Image

T-cell Lymphoma Market 2024-2028

  • Report
  • August 2024
  • 135 Pages
  • Global
From
From
Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 190 Pages
  • Global
From
Open-Angle Glaucoma Therapeutics Market 2026-2030 - Product Thumbnail Image

Open-Angle Glaucoma Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 277 Pages
  • Global
From
From
Breast Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Breast Cancer Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 168 Pages
  • Global
From
Atomoxetine Hydrochloride Market - Global Forecast 2026-2032 - Product Thumbnail Image

Atomoxetine Hydrochloride Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
From
From
Flunitrazepam Market - Global Forecast 2026-2032 - Product Thumbnail Image

Flunitrazepam Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Flumazenil Market - Global Forecast 2026-2032 - Product Thumbnail Image

Flumazenil Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
From
Hematological Malignancies - Global Strategic Business Report - Product Thumbnail Image

Hematological Malignancies - Global Strategic Business Report

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Antithrombotic Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Antithrombotic Drugs Market - Global Strategic Business Report

  • Report
  • September 2026
  • 282 Pages
  • Global
From
Deferiprone Market - Global Strategic Business Report - Product Thumbnail Image

Deferiprone Market - Global Strategic Business Report

  • Report
  • September 2026
  • 359 Pages
  • Global
From
Immune Thrombocytopenia Drugs - Global Strategic Business Report - Product Thumbnail Image

Immune Thrombocytopenia Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 384 Pages
  • Global
From
Loading Indicator